Condition: Atrial Fibrillation (AF) · Atrial Flutter · Sponsor: Ottawa Heart Institute Research Corporation
The goal of this randomized clinical trial is to learn whether patients with symptomatic atrial fibrillation or atrial flutter (AF) who require heart imaging to rule out a blood clot before cardioversion would benefit from cardiac computed tomography angiography (CCT) in the emergency department (ED) compared to current standard of care management. This will be a multicenter trial evaluating whether CCT-facilitated cardioversion in the ED reduces hospital admission, reduces repeat presentations to hospital and improves patient quality of life compared to the current standard of care. Participants will undergo CCT-facilitated cardioversion or be treated according to current standard of care while in the ED and complete quality of life questionnaires in the ED and follow-up at 30 days.
This description comes directly from the study's public registry record.
Farrah Ahmed · 613-696-7000 · fahmed@ottawaheart.ca
Yeung Yam · 613-696-7000 · yyam@ottawaheart.ca
Always discuss trial participation with your own doctor first.
| Penn State Health Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| The Ottawa Hospital Civic Campus | Ottawa, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07002450